Dr. Stephen Hahn of the U.S. Food and Drug Administration reports the agency is closely monitoring the supply chain with the expectation that the COVID-19 outbreak will impact the medical product supply chain. And this implies a high probability of disruptions to...
AstraZeneca has entered into an agreement with a Belgium-based clinical trials supply chain technology venture called N-SIDE. Not well known in the United States, N-SIDE was providing consulting to the Anglo/Nordic global pharmaceutical company and was able to...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
